MolGen announces entrance into U.S market

MolGen B.V., a single-source supplier of DNA/RNA extraction technology and services for the life sciences and biotechnology, has announced its entrance into the U.S. market with the launch of MolGen USA. 

MolGen USA is a joint venture with California-based, laboratory automation experts Todaro Robotics. MolGen USA will operate a complete commercial team and product showroom at the San Diego facility.

Maarten de Groot, CEO of MolGen B.V, said: "The opening of our U.S. headquarters is the next step in MolGen’s global expansion strategy, allowing us to provide premium products, services and consumables on demand to American-based laboratories. During the past year, our primary focus was providing extraction chemistry and equipment for scaling up SARS-CoV-2 test capacity in the Netherlands and our experience in this field will be of immediate value to partners in the United States. Our goals in the U.S. market are long term and include expansion into the agriculture industry as well as other sectors."

The MolGen product line includes the PurePrep 96, an automated DNA/RNA purification system employing magnetic separation technology that can be used for different matrices. The PurePrep 96 is able to process up to 96 samples simultaneously in a working volume of 0.04 inches and delivering results within 15-40 minutes, based on sample type and method. This purification technology is automated and enables high-speed, high-quality processing with no cross-contamination between samples or reagent carry-over.

James Slatic, CEO of Molgen USA, said: “MolGen’s track record during the COVID-19 pandemic has been outstanding and U.S. laboratories and businesses will benefit from a provider of this caliber entering the market with such a high-level of commitment.”